In line with this, inhibition of the PI3K/Akt signaling pathway resulted in increased sensitivity of cancer cells to SA (Fig. 3N, O and Table S1) accompanied by attenuating SA-induced Bcl-xL and Mcl-1 gene expressions (Fig. 3P, Q). Here, BCL2L1 is linked to cancer.